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Purpose: This qualitative study in patients with type 2 diabetes and health care professionals 
(HCPs) aimed to investigate which factors they perceive to enhance or impede medication infor-
mation provision in primary care. Similarities and differences in perspectives were explored.
Methods: Eight semistructured focus groups were conducted, four with type 2 diabetes patients 
(n=25) and four with both general practitioners (n=13) and health care assistants (n=10). Sessions 
were audio and video recorded, transcribed verbatim, and subjected to computer-aided qualita-
tive content analysis.
Results: Diabetes patients and HCPs broadly highlighted similar factors as enablers for satis-
factory medication information delivery. Perceptions substantially differed regarding impeding 
factors. Both patients and HCPs perceived it to be essential to deliver tailored information, to 
have a trustful and continuous patient–provider relationship, to regularly reconcile medica-
tions, and to provide tools for medication management. However, substantial differences in 
perceptions related to impeding factors included the causes of inadequate information, the detail 
required for risk-related information, and barriers to medication reconciliation. Medication 
self-management was a prevalent topic among patients, whereas HCPs’ focus was on fulfilling 
therapy and medication management responsibilities.
Conclusion: The findings suggest a noteworthy gap in perceptions between information 
provision and patients’ needs regarding medication-related communication. Medication safety 
and adherence may be improved if HCPs collaborate more closely with diabetes patients in 
managing their medication, in particular by incorporating the patients’ perspective. Health care 
systems need to be structured in a way that supports this process.
Keywords: medication information, patient–provider communication, type 2 diabetes, focus 
groups, primary care
Introduction
Suboptimal medication adherence among patients with type 2 diabetes mellitus (T2DM) 
has been identified,1–3 contributing to poor health outcomes and increased health care 
costs.4 Nonadherence is common among patients with chronic conditions. Adherence 
rates among seven different chronic conditions ranged from 36.8% to 80%, with 65.4% 
of diabetes patients adhering to their medication.5 A systematic review published in 2004 
found that between 36% and 93% of diabetes patients took the prescribed amount of 
oral hypoglycemic agents (OHA), and adherence to insulin ranged from 62% to 64%.1 
According to current evidence, these rates have changed little over the past 10 years.2 
This, together with the growing incidence of T2DM patients needing medication, makes 
patient adherence a central part of effective diabetes management.6
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Inadequate communication between patients and health 
care professionals (HCPs) has been suggested as one factor 
contributing to nonadherence.7 Insufficient information and a 
lack of medication knowledge can negatively affect patients’ 
medication adherence.3,8–10 Research further suggested sig-
nificant deficits in OHA knowledge, affecting patients as 
well as professionals.9
Effective communication contributes to patients’ under-
standing of their diabetes condition as well as the benefits and 
risks of a prescribed medication.10,11 Adequate medication 
information is one important component of the information–
motivation–behavioral skills model of diabetes medication 
adherence and a target for interventions to promote adherence 
to diabetes medications.12 In Germany, general practitioners 
(GPs) play a central role in coordinating diabetes care,13 
prescribing medications and consequently having a key role in 
relation to medication information processes. Improving medi-
cation information is also part of the German Health Ministry’s 
national action plan for medication safety in Germany.14
Previous investigations regarding medication adherence 
have mainly focused on the medical perspective, whereas 
T2DM patients’ perspectives have only in recent decades 
been taken into account.15,16 Qualitative research is needed 
to understand diabetes patients’ experiences with medication 
use and the degree to which patients’ information needs are 
reached to design a patient-tailored intervention in the primary 
care setting.15,17 Moreover, to reflect on current practice, the 
perspectives of T2DM patients, GPs, and health care assistants 
(HCAs; [Medizinische Fachangestellte in German]) have 
been incorporated. Equal consideration is seldom given to the 
perspectives of HCAs. HCAs, however, play an important role 
in general practice teams in Germany, with expanded roles in 
disease and care management as well as patient education.18 
By comparing the different perspectives, a better understanding 
of the factors that hinder or facilitate the provision of medica-
tion information to T2DM patients can help general practice 
teams to improve medication counseling. To gain a better 
understanding of medication information provision in diabetes 
care, the perceptions of T2DM patients and HCPs delivering 
their care require exploration. The research reported in this 
paper aims to 1) investigate which factors diabetes patients and 
HCPs (GPs and HCAs) perceive to enhance or impede medi-
cation information provision in primary care and 2) explore 
similarities and differences between perspectives.
Methods
study design
A focus group approach was adopted to explore the experi-
ences of T2DM patients and HCPs, related to medication 
information in primary care. This qualitative method capital-
izes on group dynamics, helping participants to explore and 
clarify their perspectives in ways that may not be available 
through individual interviews.19 Moreover, Kitzinger19 sug-
gests that the method is particularly useful to explore not 
only what people think, but how they think and why they 
think that way.
study participants and recruitment
Focus groups were conducted as part of a larger research 
project called INFOPAT (Information technologies for 
patient-centered healthcare, 2012–2016, http://www.infopat.
eu/), aiming to assess the needs of T2DM patients and their 
HCPs to develop tailored information technologies and a 
medication communication intervention to improve medica-
tion safety and patient–provider communication.
From April to July 2013, participants were purposefully 
recruited with an opt-in approach from the Rhine-Neckar 
region in Germany. To obtain a range of experiences, German 
or Turkish-speaking T2DM patients (aged $18 years) who 
were self-administering prescribed diabetes medications 
(OHA and/or insulin) were approached face-to-face through 
three channels: local self-help groups, GP practices, and 
during routine appointments at the University Hospital of 
Heidelberg. GPs or HCAs with diabetes expertise (self-
reported knowledge and expertise about T2DM and its 
treatment), and experienced in caring for T2DM patients, 
were recruited by letter through a list of cooperating aca-
demic teaching and research practices of the Department 
of General Practice and Health Services Research at the 
University Hospital of Heidelberg. All participants willing 
to participate in the study completed a written informed 
consent form according to the Declaration of Helsinki prior 
to the focus group discussion. The study was approved by 
the local Ethics Committee of the University of Heidelberg 
Medical Faculty (number S-673/2012). Participants received 
€50 compensation for their time and travel expenses.
Focus groups
In total, eight focus groups were created with 6–8 individu-
als per group. Four groups were created with only T2DM 
patients, three groups with GPs and HCAs together, and one 
group with GPs only. Meetings with seven focus groups were 
conducted in a meeting room at the Department of General 
Practice and Health Services Research, while the meeting 
with the group of Turkish patients was conducted in Turkish 
at the rooms of the bilingual Turkish project partner. Each 
session was facilitated by two members of the research team 
(GL, CM, or DO) and a trained note taker who was recording 
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key points and significant nonverbal behavior. Moderator 
and co-moderator had past focus group experience and had 
attended a methods workshop for group interviewing tech-
niques. Participants completed a brief questionnaire related 
to sociodemographic information anonymously. Semistruc-
tured, pilot-tested interview guides (based on a literature 
review and developed by the interprofessional research team) 
alongside a moderator guide (regarding the general conduct) 
were used to guide the discussion on medication information 
provision. Following an expert review and pilot test, minor 
changes were made to clarify question wording and sequence 
of questions in the interview guides. Interview guides were 
matched on key themes and covered participants’ experiences 
with medication-related information and included probes 
to stimulate an open discussion. The moderator summa-
rized statements made during the discussion for validation 
with participants without seeking consensus. Focus groups 
were audio and video recorded and lasted between 110 and 
130 minutes. Recruitment of new participants in the study 
was discontinued when no new aspects emerged in the group 
discussions.20
Data analysis
Audio and video recordings were transcribed verbatim 
with anonymity of participants completely protected. Data 
were analyzed using qualitative content analysis to exam-
ine patterns and themes to achieve an understanding of the 
meaningful content.21 Analysis proceeded in a stepwise 
process to structure material in codes (labels of meaning 
units), subcategories, and categories.22,23 Thematic categories 
were developed deductively based on initial theoretically 
driven categories from the interview guide and inductively 
from the text by constant comparison. Two researchers (GL, 
CM) independently read transcripts and notes thoroughly to 
gain a sense of the whole and then coded half of the data to 
establish subcategories and categories through consensus. 
At first, transcripts were deductively analyzed by assigning 
initial categories corresponding to the themes from the 
interview guide. Subsequently, categories were developed 
inductively by identifying meaning units, condensing 
these into codes, and by clustering codes into subcategories 
based on their commonalities. Throughout the iterative 
process of revisiting the data and connecting them with new 
insights, an initial coding scheme was established including 
code description and definition, inclusion and exclusion 
criteria, and example quotes. The researcher used Atlas.ti 
(Version 7.0.80), a qualitative software package, to organize 
data and proceeded with the analysis by applying the coding 
scheme to the remaining transcripts. Any new content found 
not fitting the initial coding scheme was discussed thoroughly 
with the second researcher to cross check the interpretation 
of the data and resulted in the revision of the coding scheme. 
Subsequently, material pertaining to each category was 
analyzed to refine subcategories. Finally, subcategories and 
codes were examined and compared to identify similarities 
and differences between patients and HCPs. Researchers 
met regularly throughout the study to review categories and 
subcategories, clarify individual interpretations, and resolve 
any questionable coding by discussion. These consensus 
sessions lead to the final set of categories.
Results
A total of 48 individuals, including 25 T2DM patients, 13 
GPs, and 10 HCAs, participated in 8 focus groups between 
May and July 2013. Demographic characteristics and 
recruitment of patients and professionals are displayed in 
Tables 1 and 2.
T2DM patients’ and HCPs’ perceptions resulted in two 
main categories: 1) factors perceived to enhance medication 
information provision and 2) factors perceived to impede 
information provision. Similarities and differences between 
Table 1 characteristics of patients with type 2 diabetes who 
participated in the focus groups
Patient characteristics Patient focus  
groups (n=25)
sex, women, n (%) 7 (28)
Age (years), mean ± sD, range 64±8.6, 49–77
number of years diagnosed with diabetes,  
mean ± sD, range
13.9±10.6, 0.8–38
number of other chronic conditions,  
mean ± sD, range
3.4±1.6, 1–7
First language german/Turkish, n (%) 18 (72)/7 (28)
number of different medicines per day*, n (%)
1–2 medicines 2 (8)
3–4 medicines 6 (24)
5–6 medicines 5 (20)
$7 medicines 12 (48)
Diabetes medication, n (%)
Oral hypoglycemic agents only 13 (52)
insulin only 3 (12)
Oral hypoglycemic agents and insulin 9 (36)
education, n (%)
secondary school (9 yr) 12 (48)
secondary modern school (10 yr) 5 (20)
grammar school (13 yr) 8 (32)
living in partnership, n (%) 14 (56)
Feeling burdened,a mean ± sD, range 4.96 (2.5), 0–10
recruitment through, n (%)
self-help groups 15 (60)
University hospital of heidelberg 6 (24)
general practitioner practices 4 (16)
Notes: *not restricted to diabetes medication. ascale 1–10; 10= feeling heavily burdened.
Abbreviations: sD, standard deviation; yr, number of years of schooling/education 
that the person had.
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patients’ and HCPs’ perceptions are reported. For each sub-
category, illustrative quotes are provided. For protection of 
participants’ anonymity, unique identifiers (P, patient; GP, 
general practitioner; HCA, health care assistant; FG, focus 
group) are used.
Factors perceived to enhance medication 
information provision
This first main category (Table 3) includes five subcatego-
ries: 1) tailored, adequate information, 2) trusting patient–
provider relationship, 3) medication reconciliation, 4) tools 
for medication management, and 5) a team approach to 
medication information. Overall, T2DM patients and HCPs 
had similar perceptions as to factors that would enhance 
medication information provision: the majority of codes 
were mentioned by both groups.
Tailored, adequate information
Strongest consensus among T2DM patients and HCPs was on 
the importance of providing tailored, adequate information. 
Both groups perceived that it was essential that medication 
information was delivered face-to-face and addressed patients’ 
individual needs while taking their medication history and 
health condition into account. Providing adequate information 
stepwise in a proactive and timely manner in lay language was 
seen to contribute to patients’ satisfaction with information. 
Alongside general information, both groups thought it was 
essential for T2DM patients to understand the medications’ 
therapeutic effect on clinical parameters. One patient stated:
[…] you actually have to discuss it with the doctor, because 
the impact on each person is often different, and needs to 
be matched with your blood sugar levels and related to one 
personally. [P2 FG1]
Most patients knew their actual and target glycated hemo-
globin (HbA
1c
) values and discussed these in a lively manner.
Trusting patient–provider relationship
T2DM patients and HCPs equally viewed a trusting and 
continuous patient–provider relationship as a fundamental 
Table 2 characteristics of participating health care professionals
Health care professional 
characteristics
Professional focus groups
GPs (n=13) HCAs (n=10)
sex, women, n (%) 6 (46.2) 10 (100)
Age (years), mean ± sD, range 54.1±9.2, 35–64 38.6±11.8, 21–52
structure of practice, n (%)
solo practice 4 (30.8) 4 (40)
group practice 7 (53.8) 6 (60)
Practice sharing 1 (7.7)
Ambulatory health center 1 (7.7)
Years of work experience,  
mean ± sD, range
24.5±9.8, 6–40 15.5±12.5, 0–35
Participation in DMP diabetes 
 type 2, n (%)
13 (100) 10 (100)
recruitment through, n (%)
Academic teaching practices 12 (92.3) 8 (80)
research practices 1 (7.7) 2 (20)
Abbreviations: gP, general practitioner; hcA, health care assistant; sD, standard 
deviation; DMP, disease management program.
Table 3 Factors perceived by patients and health care professionals to enhance medication information provision
Subcategory Code Source
Tailored, adequate  
information
Face-to-face and responsive communication P, hcP
reference to clinical parameters, overall therapy, considering health condition and life situation P, hcP
Proactive, timely provision of relevant information P, hcP
Use of lay language P, hcP
stepwise and repeated provision P, hcP
consideration of patients’ resources and capacity P, hcP
Trusting patient–provider  
relationship
Trust and continuity being a necessary basis P, hcP
Pivotal role of gPs in coordinating care P, hcP
responsiveness of provider P
Medication reconciliation Prerequisite to adequate information delivery P, hcP
Confidence in medication compatibility P
DMP supports medication management hcP
Brown bag review initiated on suspicion of polypharmacy, overuse, or non-adherence, etc hcP
Tools for medication  
management
Medication plan adjusted to patients’ needs P, hcP
Medication plan/graphs to facilitate proper use P, hcP
supporting patients’ daily self-management P
Updated medication plan supports providers’ medication management hcP
Team approach to  
medication communication
Professional cooperation hcP
Directing patients to further training hcP
Abbreviations: P, perceptions of patients with type 2 diabetes; hcP, health care professionals’ perceptions; gP, general practitioner; DMP, disease management program.
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condition for effective medication communication. 
For patients, a trusting relationship implied that HCPs 
were responsive to their needs, took sufficient time to dis-
cuss their concerns, and were fully informed about their 
medication. Patients’ faith in their HCP was linked with 
the view that relevant information was communicated. 
One patient stated:
I didn’t really bother about it, I somehow trust the doctor 
[…]. [P2 FG1]
GPs were named most frequently by both groups as the 
primary source of medication information and were seen as 
having a pivotal role in care coordination.
Medication reconciliation
While both T2DM patients and HCPs stated that regular 
reconciliation (systematic and comprehensive review of a 
patient’s medications to create a complete and accurate list 
of the current medication24) was a prerequisite to providing 
medication information, they put emphasis on different 
aspects. Patients described reconciliation as enhancing their 
confidence in their medication regime. HCPs in turn focused 
on medication management, and some suggested that rec-
onciliation was facilitated by the implementation of disease 
management programs (DMPs). One HCA said:
[…] as part of the DMP, I think our medication communica-
tion and plans have become more solid […]. [HCA1 FG2]
Due to time and resource constraints, however, medica-
tion reconciliation was not implemented systematically in 
daily practice, eg, brown bag reviews (patients bring all 
their medications to the HCP for comprehensive assessment) 
tended to be initiated by GPs when there were feelings of 
concern rather than being practiced as the standard.
Tools for medication management
Both groups valued tools for medication management, includ-
ing medication plans, visual displays, and comprehensible 
labeling of medicine packages. Individualized medication 
plans were seen to facilitate proper use, with the majority of 
professionals stating that they provide plans for their patients. 
However, only about half of the patients participating in this 
study had a medication plan. For most T2DM patients, it 
was particularly important that tools assisted them in self-
managing their medications. One patient described:
[…] my diabetologist. He actually made me a plan how to 
fine tune my insulin […] told me if this leads to low blood 
sugar I need to […]. [P4 FG2]
HCPs in turn emphasized that medication plans helped 
them to regularly review the medication regime of their 
chronically ill patients and to foster collaboration between 
professionals.
Team approach to medication communication
Primarily, HCPs discussed a team approach, which included 
GPs, specialists, HCAs, pharmacists, and diabetes educators 
to enhance medication information delivery. One GP reported 
about teamwork in his practice:
[…] insulin, for example, I explain how it works, what it is 
[…] how to inject, how to prepare is done by my healthcare 
assistant who’s also providing the [diabetes] training […].
[GP3 FG3]
Prescribing and medication information was in the 
responsibility of the physician; teaching and reinforcing 
information was often HCAs’ task. Although patients found 
HCAs to be more approachable than physicians, most patients 
perceived HCAs were not having specialist knowledge 
regarding their medication. HCAs also expressed a need for 
training in pharmacology to take on greater responsibility in 
providing medication-related information. For further sup-
port, physicians also referred newly diagnosed patients for 
diabetes education. HCPs, however, complained that insuf-
ficient collaboration and poor delineation of responsibilities 
in practice were an issue for them.
Factors perceived to impede medication 
information provision
The second main category (Table 4) also includes five sub-
categories: 1) inadequate information, 2) lack of/overload 
of information on potential adverse effects, 3) medication 
reconciliation impeded, 4) lack of support for medication 
self-management, and 5) system-related barriers. Overall, 
there was minimal consistency in perceptions between T2DM 
patients and HCPs on factors impeding medication informa-
tion provision, as similar codes were scarcely found.
inadequate information
T2DM patients and HCPs had distinct perceptions of what lead 
to inadequate information. Both groups identified conflicting 
information as being one aspect and highlighted patients’ 
difficulties in assessing the reliability of (online) information. 
Beyond that, HCPs emphasized that patients’ erroneous infor-
mation posed challenges to the patient–provider consultation. 
The majority of diabetes patients, however, perceived the pro-
vision of medication information by HCPs to be insufficient. 
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Most patients received information on dosing, but a few got 
as little as the recommendation “try it out” [P1 FG1].
Hence, some patients felt they were dependent on the 
engagement of their HCP. In addition, patients felt over-
loaded with certain types of information (eg, information 
leaflets, technical jargon), particularly if they could not find 
answers to specific questions or relate it to their individual 
situation. In contrast, HCPs reported that patients forgot 
information provided. A few HCPs also referred to family 
members and friends as being opinion formers, posing chal-
lenges to information provision.
lack of/overload of information on potential adverse 
effects
Perceptions of T2DM patients and HCPs differed signifi-
cantly regarding information on potential adverse effects. 
This topic was intensively discussed in all focus groups. 
Most patients perceived that they had a lack of adequate 
information about side effects, drug–drug interactions, and 
long-term effects of their prescribed medications, and the 
majority wished their HCPs to be more forthcoming with 
this information. Two patients reported experiencing epi-
sodes of hypoglycemia without much knowledge about this 
threatening situation and a lack of prior guidance as to how 
to cope with it. A few patients also described being nonad-
herent due to insufficient information and concerns about 
adverse effects. However, two patients also described not 
seeking information on adverse effects due to concern about 
its potentially negative impact. In contrast, the majority of 
HCPs were ambivalent toward discussing risk information in 
detail with patients. GPs cited the need to use their judgment 
when communicating this information:
[ …] if I tell forty side effects for each medication. 
[GP2 FGI] […] nobody will take it. [GP3 FG1]
HCPs were concerned about increasing patient fear, 
resulting in increased nonadherence and numerous discus-
sions. Nevertheless, HCPs believed that patients needed to 
be made aware of the most common side effects in order to 
self-monitor their medication and have strategies to minimize 
them. Detailed risk information provided by other sources, 
including the internet or pharmacists, was viewed critically.
Medication reconciliation impeded
Although a full overview of T2DM patients’ current medication 
was viewed as being crucial to provide adequate medication 
Table 4 Factors perceived by patients and health care professionals to impede medication information provision
Subcategory Code Source
inadequate information Conflicting information from different sources P, hcP
not user-friendly, overload with certain information Pa
Insufficient information, dependent on discretion of provider Pa
Patients’ forgetting information hcPa
Family members and friends being opinion formers hcPa
lack of/overload of information  
on potential adverse effects
information not proactively provided Pa
lack of information causes uncertainty/noncompliance Pa
lack of guidance how to cope with adverse effects Pa
Detailed information creates fear/nonadherence hcPa
Risks and benefits are not balanced in patient information leaflets hcPa
Medication reconciliation impeded lack of cross sectorial collaboration/full medication overview impeded P, hcP
lack of discussion of overall medication Pa
Time consuming hcP
no reimbursement hcP
lack of patients’ mutual collaboration hcPa
lack of support for medication  
self-management
Overwhelmed with insulin administration P, hcP
Predetermined treatment plan not fitting daily life P, hcP
self-management is challenging P
Planning medication use and administration P
loss of security due to medication changes P
system-related barriers restricted consultation time/no reimbursement P, hcP
Drug discount contracts confuse patients P, hcP
lack of transparency of reimbursement system P
Drug discount contracts impose challenges on practices/black box for physicians hcP
Deficient medication labeling hcP
Note: aConflicting perceptions.
Abbreviations: P, perceptions of patients with type 2 diabetes; hcP, health care professionals’ perceptions.
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information, both groups’ perceived barriers to realize medica-
tion reconciliation in practice. The majority of HCPs named 
time constraints, a lack of reimbursement, and cross sectorial 
collaboration as significant barriers to implement medication 
reconciliation in practice. One GP reported:
[…] medication reconciliation with nursing homes, phar-
macies, specialists, self-medication […] doesn’t work. 
[GP3 FG1]
But, there were also differences in patient and HCP 
perceptions. Diabetes patients perceived that the discussion 
about the medication regime overall was lacking, particularly 
when medicines were changed or new ones were prescribed. 
HCPs in turn stated that they were reliant on patients’ mutual 
cooperation to adequately assess a patient’s medication. 
In addition, HCPs perceived that patients had difficulties in 
accurately recalling their current medications, were reluctant 
to tell what else they were taking, or had a different under-
standing what constituted a medication.
lack of support for medication self-management
Medication self-management, defined as the range of tasks 
patients have to undertake to successfully manage their 
therapeutic regime and sustain safe medication use over 
time,25 was a prevalent topic among T2DM patients. Patients 
frequently commented on the challenges of self-managing 
their medications and fitting their regime into daily life. Two 
patients admitted to frequently forgetting to take a dose at 
a scheduled time and therefore took the dose later that day. 
Other patients mentioned that they were unsure of how to 
proceed if they missed a dose. A few patients reported unsat-
isfactory support regarding insulin administration:
[…] my doctor gave me the insulin injections and said 
“inject 12 units” and that’s it. No clarification that it can 
cause hypo’s [hypoglycemia], neither how to inject, I didn’t 
know. I did inject incorrectly the whole time at the wrong 
spot […] I hurt myself […]. [P4 FG2]
Patients’ difficulties with insulin administration were 
also recognized by HCPs. A few patients also reported of 
problems with adherence to their predetermined treatment 
plan, as it did not fit their everyday life. Likewise, one GP also 
underlined that the information needed to suit the individual 
circumstances (eg, familial and occupational circumstances) 
of the patient. He described:
[…] I always write down morning, noon, evening and night 
[…] I had a diabetic patient saying he injects twelve units 
insulin in the morning […] very poor sugar […] we found 
out he’s a baker, for whom morning is actually half past 
midnight […]. [GP3 FG3]
Most T2DM patients had complex medication regimes 
($5 different types of medicines taken regularly per day), and 
changes were often experienced as a loss of security. It was 
clear from the responses of patients that some lacked strate-
gies to accomplish the tasks to self-manage their medication 
on a daily basis. Moreover, medication self-management 
appeared to receive little attention in the patient–provider 
communication, as physicians seemed to focus rather on 
therapy and medication management responsibilities. 
Interestingly, however, most patients had low expectations 
regarding self-management support from their HCPs.
system-related barriers
T2DM patients, and particularly HCPs, repeatedly stressed 
that system-related barriers including time and resource 
constraints as well as drug discount contracts impeded the 
provision of medication information. One patient stated:
[…] basically there is no one who directly tells you why 
the medication now works […] even the specialists do not 
have the time […]. [P7 FG4]
Some patients even felt uncomfortable asking for informa-
tion during medical consultations. Although HCPs recognized 
the importance of providing adequate medication informa-
tion, they felt restricted by a lack of time and resources. The 
negative impact of drug discount contracts was frequently 
discussed by patients and HCPs. For instance, when a generic 
alternative was dispensed, most patients expressed being 
confused by the changed packaging and mentioned concerns 
regarding adverse effects. Likewise, HCPs stressed:
[…] that’s an on-going topic […] they [patients] no longer 
know which medication is which and take them incorrectly 
and a lot come to the practice reception desk and bring all 
their boxes with them […]. [HCA4 FG1]
Many HCPs reported challenges this imposed on their 
practice and saw it as a negative trade-off for other impor-
tant aspects of their work. Furthermore, HCPs emphasized 
the need to improve medication labeling and appearance to 
facilitate understanding by patients.
Discussion
This qualitative study enabled a richer understanding and 
comparison of the perceptions of T2DM patients and general 
practice teams regarding the factors enhancing or imped-
ing medication information provision within participants’ 
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broader perspectives about diabetes care and health service 
delivery in Germany. The disagreement points out a gap 
between the ideal and the real-world information delivery. 
Although a number of similar factors have been identified 
as enhancing medication information, T2DM patients and 
HCPs showed divergent understanding of factors impeding 
medication information.
For instance, perceptions considerably differed in what 
led to inadequate information. Patients considered medica-
tion information to be insufficient or not user-friendly due 
to either inadequate physician–patient communication or the 
manner in which information was provided. In fact, research 
suggests that patients with chronic conditions have a lack of 
information and poor understanding of medication use9 and 
may therefore poorly adhere with their medication regime.8,15 
According to HCPs, inadequate information was either due 
to patients forgetting information26 or receiving unreliable 
information from sources other than HCPs (eg, internet, 
family members). Indeed, conflicting medication information 
may negatively influence medication adherence, and hence, 
a supportive physician should provide patients with reliable 
information sources.27
Notably, T2DM patients and HCPs had conflicting views 
regarding how much information on potential adverse effects 
should be provided. In this study and others,28 most patients 
wanted detailed information about adverse effects, but 
experienced professionals were not forthcoming with this 
information. Deficits in both diabetes patients’ and HCPs’ 
knowledge about relevant adverse effects of OHA have also 
been cited.9 In contrast, HCPs were primarily concerned that 
detailed information about adverse effects could increase 
patients’ fear and thus nonadherence,29 although research 
suggests that informing patients about adverse effects does 
not negatively affect medication adherence.30 However, as 
a small proportion of patients did not want any information 
about adverse effects, it is emphasized that particularly risk 
information needs to be tailored to individual needs.
The lack of support for medication self-management was 
regarded by T2DM patients in this study as a point of particu-
lar dissatisfaction with regard to medication information and 
might put some patients at risk for medication-related pro-
blems. In particular, complex medication regimes and regime 
changes might elicit a special need for self-management 
support. Patients’ difficulties to adhere to complex medication 
regimes have also previously been reported.31 Furthermore, 
some information and support required by T2DM patients 
were specifically related to insulin injection therapy (eg, dose 
adjustments, injection technique). Although physicians are 
regarded as a primary information source, this prominent issue 
for T2DM patients does not appear to be at the center of HCPs’ 
attention. This might also be explained in patients “mirror-
ing” physicians, resulting in low expectations regarding the 
provision of self-management support. HCPs, however, 
have an important role in assisting and supporting patients’ 
medication self-management and should therefore actively 
seek to collaborate with patients who have problems with 
self-management.32,33 The findings indicate a need for HCPs 
to reevaluate how they provide information and self-manage-
ment support, particularly related to insulin use or managing 
complex regimes, to their patients. Moreover, HCPs should 
collaborate more closely with patients to recognize their needs 
and apply multifaceted strategies (eg, tailored instructions, 
encouragement, tools supporting routine development) appro-
priate to patients’ individual circumstances. Overall, more 
attention needs to be devoted to patients’ self-management 
during all medical encounters.
Although both HCPs and T2DM patients valued medi-
cation reconciliation, structural constraints and insufficient 
collaboration between professionals (eg, GPs, specialists, 
and pharmacists) restrict the extent to which reconciliation 
can be achieved. Besides an interprofessional approach, 
patient participation has also been emphasized by HCPs as 
being crucial to enhance the accuracy of medication lists.34 
Feedback and better education of HCPs35 and patients on 
the importance of medication reconciliation and a common 
understanding regarding what constitutes a medication are 
suggested to reduce medication discrepancies, improve 
patient satisfaction with medication-related information, and 
cross sectorial collaboration.34
System-related barriers were a recurring and underly-
ing theme in both groups. While T2DM patients perceived 
that lack of time impeded discussions and the provision of 
adequate information, HCPs felt restricted in achieving their 
therapy and medication management responsibilities. This 
situation is further impeded by the impact of drug discount 
contracts. Previous research confirmed that changes in 
patients’ medications due to discount contracts resulted in 
feelings of insecurity or confusion about medication intake.36 
These circumstances impose challenges to GPs to fulfill the 
increased need for advice and eliminate diabetes patients’ 
uncertainties without adequate system support. For a more 
cost-effective solution, appropriately trained HCAs could 
take on a more vital role in reviewing and communicating 
medication-related information.37
All in all T2DM patients and HCPs broadly highlighted 
the same enablers for satisfactory medication information. 
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Previous research also highlighted the importance of a 
patient-directed communication approach to effectively 
deliver medication information,38 improve patient adherence,7 
and foster concordance between patients and HCPs.39 
A synthesis of qualitative studies concluded that informa-
tion sharing requires a collaborative relationship, in which 
the knowledge and experiences of the individual patient are 
valued.40 Similar to Thom et al’s41 study, T2DM patients 
appreciated receiving information from HCPs with whom 
they felt comfortable asking questions, raising concerns, and 
being listened to. Positive experiences made in the medical 
encounter increased patients’ trust in their HCP. In fact, 
evidence suggests that patient trust is related to treatment 
adherence. Moreover, the current study supports the critical 
role of a structured and collaborative approach to medica-
tion reconciliation to maximize the quality and safety of 
care. Diabetes patients viewed medication reconciliation 
as enhancing their confidence in their medication regime, 
whereas HCPs viewed it as an important component of their 
medication management. Tools for medication management 
were also seen to benefit patients and HCPs alike by increas-
ing patients’ participation, fostering self-management,4 and 
assisting reconciling medicines across the care continuum.34 
Thus, it is essential that every patient possesses a complete 
and accurate medication list. Similar to HCPs perceptions 
in this study, research suggests that adequate medication 
communication requires a collaborative approach and clear 
delineation of responsibilities.29 Although GPs were viewed 
as the primary information source, improving the coopera-
tion with other members of the health care team (eg, phar-
macists, HCAs, diabetes educators, nurses) is necessary to 
fulfill all patients’ information needs. Moreover, patients in 
particular do not seem to be aware of which information to 
expect from different HCPs. For instance, pharmacists have 
the expertise to initiate counseling (eg, application, side 
effects) and medication reconciliation activities to ensure 
safe and appropriate medication use, but they are currently 
an underutilized resource.
The implementation of a structured medication manage-
ment intervention (eg, medication reconciliation, computer-
assisted medication check, medication list) into existing 
practice structures (eg, DMP counseling)42 can support 
patients in their self-management while enhancing HCP’s 
medication management.
One of the strengths of this study is that the perspectives 
of T2DM patients, GPs, and HCAs were incorporated. 
Participants, however, may have a greater interest in medica-
tion communication and may represent the perspectives of 
more adherent patients or supportive HCPs. Consequently, 
we do not know the perspective of potential participants who 
chose not to participate. Moreover, this study did not spe-
cifically focus on low-literate, low-adherent T2DM patients, 
their caregivers, or other HCP groups. Incorporating their 
experiences may have generated a fuller picture of the situa-
tion. While multiple coding is recommended throughout the 
process to increase reliability, only half of the entire dataset 
was coded independently by two researchers for pragmatic 
reasons. This was considered justifiable as the coding scheme 
only needed slight adaptation. To compensate this weakness, 
the researchers thoroughly discussed any new content or 
disagreement found with the initial coding scheme to reach 
consensus on the final set of categories. Despite the limita-
tions, our study provides important information on factors 
which may explain some of the current challenges in the 
provision of medication information.
Conclusion
The findings identify a gap in perceptions between what 
information is provided to T2DM patients and what is wanted 
from patients during medication-related communication. 
These differences in perceptions relate to the adequacy 
of medication and risk information with patients, placing 
emphasis on assistance with medication self-management, 
whereas HCPs are concerned about their therapy and medica-
tion management responsibilities. The current gap in medica-
tion communication expectations may give the impression 
that it is of little importance in diabetes management. 
However, medication information needs a firm place in the 
patient–provider consultation and should also play a central 
role in professional training and cross sectorial collaboration. 
Optimal medication information may be achievable if HCPs 
collaborate more closely with patients in managing diabetes 
medication and if health care systems support this process 
to achieve favorable outcomes. Moreover, it is clear that 
patients’ perspective on medication information should be 
incorporated in the patient–provider consultation. Accord-
ingly, a first step in communicating with T2DM patients 
about their medication is recognizing needs, beliefs, and 
values they hold.
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